PTEN Oxidation Promotes Constitutive PI3K Signaling and Inducible Macropinocytosis in Pancreatic Cancer.
Saved in:
| Title: | PTEN Oxidation Promotes Constitutive PI3K Signaling and Inducible Macropinocytosis in Pancreatic Cancer. |
|---|---|
| Authors: | Burge RA; Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina., Bialousow L; Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina., Linke AJ; Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina., Coalson HS; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia Health System, Charlottesville, Virginia., Adair SJ; Department of Surgery, University of Virginia, Charlottesville, Virginia., Sundararaj K; Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina., Smith M; College of Graduate Studies, Medical University of South Carolina, Charleston, South Carolina., Bumbleburg C; College of Graduate Studies, Medical University of South Carolina, Charleston, South Carolina., Bauer TW; Department of Surgery, University of Virginia, Charlottesville, Virginia., Kashatus DF; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia Health System, Charlottesville, Virginia., Hobbs GA; Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina.; Hollings Cancer Center, Charleston, South Carolina. |
| Source: | Cancer research [Cancer Res] 2026 Apr 15; Vol. 86 (8), pp. 1854-1867. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
